NOVT - Company ID 0001076930
NOVANTA INC trades as NOVT and has a market capitalization of $5.57 B, making it the #1338 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $980.60M, up 3.3% from the prior year and net income of $53.83M. This page tracks NOVANTA INC through 1,533 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years NOVANTA INC's revenue grew from $384.76M to $980.60M, a compound annual growth rate of 11.0%. Net profit margin compressed from 5.7% to 5.5% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-15 |
| Insider trade | 4 | 2026-05-14 |
| Insider sale notice | 144 | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-11 |
| Major company event | 8-K | 2026-05-11 |
| Insider trade | 4 | 2026-05-07 |
| Insider sale notice | 144 | 2026-05-05 |
| SCHEDULE 13G | - | 2026-04-30 |
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Jefferies Global HealthcareConference on Thursday, June 4, 2026, in New York, NY.
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026, in New York, NY.
Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges. This enables Novanta to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation, the Novanta Growth System, and our customers’ success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT.”
**First Quarter 2026 GAAP Revenue increased 10% to $258 million**
A replay of the audio webcast will be available approximately three hours after the conclusion of the call on the Events & Presentations page of the Investors section of the Company’s website at www.novanta.com. The replay will remain available until Monday, July 06, 2026.
The largest companies sharing NOVANTA INC's SEC industry classification (miscellaneous electrical machinery, equipment & supplies).
NOVANTA INC (NOVT) has a market capitalization of $5.57 B as of 2026-07-09, ranking #1338 among US-listed companies.
NOVANTA INC reported revenue of $980.60M for fiscal year 2025, an increase of 3.3% year over year.
Yes. NOVANTA INC reported net income of $53.83M in its latest fiscal year.